Betahistine Dihydrochloride (betahistine hydrochloride) contains not less than 99.0% and not more than 101.0% of C8H12H2‧2HCl, calculated on the dried basis.

共有 1 個藥物證書使用此成份

鹽酸貝他喜汀
Betahistine Dihydrochloride

• 申請商: 鴻傑藥品有限公司
• 適應症: 治療梅尼艾氏症候群所引起之眩暈、聽力障礙。
• 發證日期: 2016-04-12